Helmerich & Payne saw its IBD SmartSelect Composite Rating rise to 96 Tuesday, up from 90 the day before.
The new rating is a sign the stock is outpacing 96% of all stocks when it comes to the most important stock-picking criteria.
Helmerich & Payne is not currently near a proper buy zone. It is starting to move higher after a failed breakout from a cup with handle pattern. Now we look for the stock to form and break out of a new base.
See How IBD Helps You Make More Money In Stocks
The stock has an 83 EPS Rating, meaning its recent quarterly and annual earnings growth is outpacing 83% of all stocks.
Its Accumulation/Distribution Rating of B- shows moderate buying by institutional investors over the last 13 weeks.
The company posted a 304% earnings gain for Q3. Revenue growth came in at 32%, down from 65% in the prior quarter.
Helmerich & Payne earns the No. 1 rank among its peers in the Oil & Gas-Drilling industry group. Noble and ChampionX are also among the group's highest-rated stocks.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
